PAVmed Inc. Reports Q3 Non-GAAP EPS of -$0.19, Exceeding Analyst Expectations
PAVmed Inc. (PAVM) has released its third-quarter financial results, reporting a Non-GAAP earnings per share (EPS) of -$0.19. This figure represents a significant beat compared to market expectations, surpassing analyst estimates by $0.47. The report highlights the company's ongoing efforts to manage losses while navigating its current fiscal cycle. While the company remains in a loss position on a Non-GAAP basis, the substantial earnings surprise suggests better-than-anticipated operational performance or cost management during the quarter.